Investing in InfuSystem Holdings Inc (INFU): What You Must Know

InfuSystem Holdings Inc’s recent filing unveils that its Director Eichenbaum Kenneth D. acquired Company’s shares for reported $10360.0 on May 28 ’25. In the deal valued at $5.18 per share,2,000 shares were bought. As a result of this transaction, Eichenbaum Kenneth D. now holds 6,000 shares worth roughly $36420.0.

Then, Richard Dilorio bought 20,000 shares, generating $122,000 in total proceeds.

Before that, Hundzinski Ronald T bought 5,000 shares. InfuSystem Holdings Inc shares valued at $30,450 were divested by the Director at a price of $6.09 per share. As a result of the transaction, Hundzinski Ronald T now holds 5,000 shares, worth roughly $30350.0.

Roth Capital initiated its InfuSystem Holdings Inc [INFU] rating to a Buy in a research note published on July 22, 2025; the price target was $12. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Northland Capital began covering INFU with “an Outperform” recommendation on April 26, 2021. Sidoti started covering the stock on December 29, 2020. It rated INFU as “a Buy”.

Price Performance Review of INFU

On Tuesday, InfuSystem Holdings Inc [AMEX:INFU] saw its stock jump 3.76% to $6.07. Over the last five days, the stock has gained 3.58%. InfuSystem Holdings Inc shares have fallen nearly -8.17% since the year began. Nevertheless, the stocks have fallen -28.17% over the past one year.

How much short interest is there in InfuSystem Holdings Inc?

A steep rise in short interest was recorded in InfuSystem Holdings Inc stocks on 2025-07-15, dropping by -0.44 million shares to a total of 0.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 0.61 million shares. There was a decline of -262.72%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on August 31, 2020 when Craig Hallum began covering the stock and recommended ‘”a Buy”‘ rating along with a $28 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.